VP Medical Affairs: Build External Strategy & KOL Network

Elutia; San Diego (CA); Sur place; USD 250 000 - 450 000; Plein temps

Résumé du poste

Elutia is building its Medical Affairs function as FDA decisions for NXT-41 and NXT-41x approach. The Vice President of Medical Affairs will create and lead this function, sit at the leadership table, and shape external engagement with surgeons, researchers, and the public.

The role emphasizes building and managing a team, engaging KOLs, leading clinical operations for trials, and guiding medical communications and publications to support commercial partnerships while maintaining scientific

Qualifications

• Experience leading medical affairs in medtech or biotech environments.
• Strong ability to build cross-functional teams and strategic plans.
• Track record of managing medical information and scientific communications.

Responsabilités

• Lead the Medical Affairs Team across strategy, medical information, scientific communications, field medical/MSLs, and medical education.
• Engage KOLs and investigators, including advisory boards and scientific exchanges.
• Oversee scientific training across the organization and publication strategy.
• Own conference and congress planning and execution.
• Lead clinical operations for trials including investigator and site engagement, IRB representation, and CRO oversight.
• Ensure medical messaging stays within approved claims while maintaining scientific independence.

Connaissances

Team leadership

KOL engagement

Clinical operations

Scientific communication

Medical information management

Description du poste

Elutia is building its Medical Affairs function as FDA decisions for NXT-41 and NXT-41x approach. The Vice President of Medical Affairs will create and lead this function, sit at the leadership table, and shape external engagement with surgeons, researchers, and the public.

The role emphasizes building and managing a team, engaging KOLs, leading clinical operations for trials, and guiding medical communications and publications to support commercial partnerships while maintaining scientific